29. Michalowicz BS, Aeppli DP, Kuba RK, et al. A twin study of genetic variation in proportional radiographic alveolar bone height. J Dent Res. 1991;70( 11):1431-1435.

30. Van Dyke TE, Dave S. Risk factors for periodontitis [review]. J Int Acad Periodontol. 2005; 7( 1): 3-7.

31. Kim DM, Ramoni MF, Nevins M, et al. The gene expression profile in refractory periodontitis patients. J Periodontol. 2006;77( 6):1043-1050.

32. Mealey BL, Oates TW; American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol. 2006;77( 8):1289-1303.

33. Holzhausen M, Rossa Júnior C, Marcantonio Júnior E, et al. Effect of selective cyclooxygenase- 2 inhibition on the development of ligature-induced periodontitis in rats. J Periodontol.

2002;73( 9):1030-1036.

34. Jeffcoat MK, Reddy MS, Haigh S, et al. A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol. 1995;66( 5):329-338.

35. Hasturk H, Kantarci A, Ohira T, et al. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J. 2006; 20( 2): 401-403.

36. Jain A, Batista EL Jr., Serhan C, et al. Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun. 2003;71( 10): 6012-6018.

37. Ashley RA. Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. SDD Clinical Research Team. Ann N Y Acad Sci. 1999;878: 335-346.